Navigation Links
Research center to develop next generation of advanced chemical products
Date:3/28/2014

A new 7 million centre at the University of Leeds will lead UK research in manufacturing advanced chemical products.

The Centre for Doctoral Training (CDT) in Complex Particulate Products and Processes will fund 50 new research students in a field that has been targeted by the Government as a key growth area for the UK economy.

"Advanced formulated chemical products are worth more than 200 billion a year to the UK economy and are used in a wide range of sectors, from advanced drugs and protecting crops through to the toiletries we use," said Professor Simon Biggs, of the University of Leeds' Faculty of Engineering, who led the bid. "Our centre will be working across the whole supply chain, whether that's discovering new materials, getting these things on the manufacturing line or delivering them to consumers."

The new facility is one of 22 new CDTs announced by the Chancellor of the Exchequer, the Rt. Hon George Osborne MP, in Manchester today (March 28, 2014). Government money, allocated by the Engineering and Physical Science Research Council (EPSRC), will provide more than half of the centre's funding, with the remainder coming from the University and industrial partners.

Companies backing the CDT include the multinational consumer goods company Procter & Gamble (P&G), agrochemical developer Syngenta, petroleum additives manufacturer Infineum and major drug companies including GlaxoSmithKline, Pfizer and AstraZeneca.

Professor Biggs said: "This is not just about researchers sitting in their labs formulating clever materials. One of the problems in research is that a molecule might be ideal in theory but it may be impossible to manufacture it at scale and at a cost that can be supported by the market.

"We are going to be training researchers who can see the whole picture. An engineer looking at manufacturing problems will need to understand the limitations and restrictions of the chemist. The chemist will need to engage with the production line and the market. They will work in cross-disciplinary teams. The focus is on developing people who can go out there and continue the UK's leadership in this field."

One key area of work is "micro encapsulation," which allows active ingredients in products such as drugs, agrochemicals, foods, cleaning products and toiletries to be better targeted.

"Think about chemotherapy. It kills cancer cells but it also kills off a lot of good tissue. If we can encapsulate those active ingredients on the micro-scale, so that they are only released on the cancer cells, we could give you a lot less drug and be better at targeting the cancer. We might also be reducing the cost of the drug because we need a lot less active ingredient," Professor Biggs said.

Other applications include micro capsules that slowly leak active ingredients in pesticides, protecting a plant over an extended period, or micro-packages that preserve active ingredients in cleaning products so that they remain effective after months in the supply chain.

"A Malteser is an 'encapsulated' piece of honeycomb. Our honeycomb might be a drug, an agrochemical, something in your shampoo or an additive to your engine lubricant," Professor Biggs said.

The CDT will involve academics from the University's School of Process, Environmental and Materials Engineering, School of Mechanical Engineering, School of Chemistry, School of Design, School of Food Science and Nutrition and Leeds University Business School.

Research students are expected to be recruited from backgrounds including chemistry, physics, material engineering, product engineering and product design.

The first cohort of 10 PhD students will start work in October.
'/>"/>

Contact: Chris Bunting
c.j.bunting@leeds.ac.uk
44-011-334-32049
University of Leeds
Source:Eurekalert

Related biology news :

1. Research from CHORI scientists demonstrates first genome methylation in fruit fly
2. GW researcher invents mini heart to help return venous blood
3. Clemson researcher touts surgical safety checklist to save lives
4. Researchers at IRB discover a key regulator of colon cancer
5. Researchers reveal the dynamics behind Arctic ecosystems
6. IRCM researchers uncover a new function for an important player in the immune response
7. HFSP research funding for the Helmholtz Zentrum München
8. UGA researchers explore function of cancer-causing gene
9. CASIS-sponsored research heads to space station aboard SpaceX-3
10. Distinguished researcher to speak at NJIT on preventing bone loss
11. Researchers present comprehensive roadmap of blood cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., a ... Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas ... practices and how Proscia improves lab economics and realizes an increase in diagnostic ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
Breaking Biology Technology: